Groupe Hospitalier Diaconesses Croix Saint Simon   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Paris France (2002)

Organization Overview

First Clinical Trial
2016
NCT03025477
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Groupe Hospitalier Diaconesses Croix Saint-Simon | Groupe Hospitalier Diaconessess Croix Saint Simon | Hopital Diaconesses - La Croix Simon

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 2)

Ovarian Neoplasms (Phase 2)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6